During this session, involved parties will present scientific findings in both support and opposition to the claims asserting that the use of Ozempic has resulted in significant gastrointestinal issues, such as gastroparesis, ileus, and intestinal obstructions, among other adverse conditions, experienced by the plaintiffs
, , ,
Current opinion in clinical nutrition and metabolic care
Across the wider body of data, alopecia is classed as a common event, meaning at least one in a hundred people treated, at 2.5% versus 1.0% on placebo
Lei G, Zhang Y, Koppula P, Liu X, Zhang J, Lin SH, Ajani JA, Xiao Q, Liao Z, Wang H, Gan B